Free Trial

Proficio Capital Partners LLC Has $245,000 Stake in Aflac Incorporated (NYSE:AFL)

Aflac logo with Finance background

Proficio Capital Partners LLC reduced its holdings in Aflac Incorporated (NYSE:AFL - Free Report) by 98.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,201 shares of the financial services provider's stock after selling 189,715 shares during the quarter. Proficio Capital Partners LLC's holdings in Aflac were worth $245,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of the business. Golden State Wealth Management LLC grew its stake in shares of Aflac by 121.9% during the 1st quarter. Golden State Wealth Management LLC now owns 304 shares of the financial services provider's stock worth $34,000 after acquiring an additional 167 shares in the last quarter. Dynamic Advisor Solutions LLC bought a new position in Aflac in the first quarter valued at $206,000. GAMMA Investing LLC grew its position in Aflac by 11.6% in the first quarter. GAMMA Investing LLC now owns 13,527 shares of the financial services provider's stock valued at $1,504,000 after purchasing an additional 1,411 shares in the last quarter. Garde Capital Inc. bought a new position in Aflac in the first quarter valued at $36,000. Finally, Sowell Financial Services LLC bought a new position in Aflac in the first quarter valued at $865,000. 67.44% of the stock is owned by institutional investors.

Analyst Ratings Changes

AFL has been the subject of several analyst reports. Wall Street Zen cut Aflac from a "hold" rating to a "sell" rating in a report on Monday, May 5th. Raymond James Financial decreased their price target on Aflac from $115.00 to $110.00 and set an "outperform" rating for the company in a research note on Thursday, May 29th. UBS Group raised their target price on shares of Aflac from $109.00 to $114.00 and gave the company a "neutral" rating in a research note on Wednesday, April 2nd. Piper Sandler raised their target price on shares of Aflac from $118.00 to $124.00 and gave the company an "overweight" rating in a research note on Wednesday, April 2nd. Finally, Wells Fargo & Company lifted their price objective on shares of Aflac from $103.00 to $105.00 and gave the company an "equal weight" rating in a research report on Thursday, July 10th. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat, Aflac currently has a consensus rating of "Hold" and a consensus target price of $108.15.

View Our Latest Stock Report on AFL

Insider Activity at Aflac

In related news, Director Masatoshi Koide sold 37,000 shares of Aflac stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $105.59, for a total transaction of $3,906,830.00. Following the sale, the director directly owned 70,992 shares in the company, valued at $7,496,045.28. This trade represents a 34.26% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Arthur Reginald Collins sold 2,750 shares of Aflac stock in a transaction on Thursday, May 15th. The stock was sold at an average price of $105.70, for a total transaction of $290,675.00. Following the transaction, the director owned 6,728 shares in the company, valued at approximately $711,149.60. This trade represents a 29.01% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 40,750 shares of company stock valued at $4,304,295 in the last 90 days. 0.90% of the stock is owned by corporate insiders.

Aflac Price Performance

Shares of AFL stock traded up $0.95 during trading on Friday, hitting $103.40. The company had a trading volume of 2,023,594 shares, compared to its average volume of 2,454,763. Aflac Incorporated has a one year low of $94.03 and a one year high of $115.50. The stock's 50-day moving average price is $103.04 and its 200 day moving average price is $105.17. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.09 and a current ratio of 0.09. The firm has a market capitalization of $55.90 billion, a P/E ratio of 16.16, a price-to-earnings-growth ratio of 3.16 and a beta of 0.81.

Aflac (NYSE:AFL - Get Free Report) last issued its earnings results on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share for the quarter, missing analysts' consensus estimates of $1.67 by ($0.01). Aflac had a net margin of 21.27% and a return on equity of 15.55%. The business had revenue of $3.40 billion during the quarter, compared to analyst estimates of $4.53 billion. During the same period in the prior year, the business posted $1.66 EPS. The company's revenue for the quarter was down 37.5% compared to the same quarter last year. Equities analysts expect that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Aflac Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 2nd. Investors of record on Wednesday, May 21st were issued a dividend of $0.58 per share. This represents a $2.32 annualized dividend and a dividend yield of 2.24%. The ex-dividend date was Wednesday, May 21st. Aflac's dividend payout ratio (DPR) is 36.25%.

About Aflac

(Free Report)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Featured Stories

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Should You Invest $1,000 in Aflac Right Now?

Before you consider Aflac, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aflac wasn't on the list.

While Aflac currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines